Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) and POEMS syndrome are difficult to differentiate at early stages. But this 2-step protocol could help.

(MENAFN- GetNews) DelveInsight's "Chronic inflammatory demyelinating polyneuropathy (CIDP) Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

This report provides comprehensive information on the therapeutic development for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), complete with comparative analysis at various stages ...

Eliashiv S, Brenner T, Abramsky O et al. Acute inflammatory demyelinating polyneuropathy following bone marrow transplantation. Bone Marrow Transplant 1991; 8: 315–317. CAS PubMed Google Scholar ...

The ADHERE trial was a multicenter, randomized, double-blind, placebo-controlled trial evaluating VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of chronic ...

A 60-year-old man regains mobility after advanced treatment. AGMC and GB Pant Hospital in Tripura mark a milestone in ...

Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® (normal immunoglobulin [human] 10% and recombinant human hyaluronidase ...

POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes) can easily be confused with chronic inflammatory demyelinating polyneuropathy (CIDP ...